These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 12458352
1. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Vogel GE. Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352 [Abstract] [Full Text] [Related]
3. [Critical review of anti-influenza drugs]. van Loon FP, Voordouw AC, Simonian S, Koopmans PP. Ned Tijdschr Geneeskd; 2000 Jan 22; 144(4):165-7. PubMed ID: 10668542 [Abstract] [Full Text] [Related]
4. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb 22; 15(81):21-30. PubMed ID: 16548114 [Abstract] [Full Text] [Related]
5. Neuraminidase inhibitors for influenza. Moscona A. N Engl J Med; 2005 Sep 29; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
6. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study. Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A. J Infect; 2000 Jan 29; 40(1):42-8. PubMed ID: 10762110 [Abstract] [Full Text] [Related]
7. [Neuraminidase inhibitor]. Kaji M. Nihon Rinsho; 2000 Nov 29; 58(11):2293-8. PubMed ID: 11225320 [Abstract] [Full Text] [Related]
8. [New diagnostic possibilities and medications. Fit for influenza?]. Wutzler P. MMW Fortschr Med; 2002 Nov 28; 144(48):18. PubMed ID: 12532540 [No Abstract] [Full Text] [Related]
9. Updated treatment for influenza A and B. Montalto NJ, Gum KD, Ashley JV. Am Fam Physician; 2000 Dec 01; 62(11):2467-76. PubMed ID: 11130232 [Abstract] [Full Text] [Related]
10. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors. Höffken G, Gillissen A. Med Microbiol Immunol; 2002 Dec 01; 191(3-4):169-73. PubMed ID: 12458354 [Abstract] [Full Text] [Related]
11. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]. de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD. Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):73-9. PubMed ID: 14753128 [Abstract] [Full Text] [Related]
12. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K. N Engl J Med; 1997 Sep 25; 337(13):874-80. PubMed ID: 9302301 [Abstract] [Full Text] [Related]
13. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE, Expert Group, German Association for the Control of Virus Diseases and Paul-Ehrlich Society of Germany. J Clin Virol; 2004 Oct 25; 31(2):84-91. PubMed ID: 15364262 [Abstract] [Full Text] [Related]
14. Neuraminidase inhibitors for treatment of influenza. Ebell MH. Am Fam Physician; 2004 Jun 15; 69(12):2824. PubMed ID: 15222647 [No Abstract] [Full Text] [Related]
15. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia. Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW. Commun Dis Intell Q Rep; 2003 Jun 15; 27(4):542-7. PubMed ID: 15508516 [Abstract] [Full Text] [Related]
16. Zanamivir: from drug design to the clinic. Elliott M. Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1885-93. PubMed ID: 11779388 [Abstract] [Full Text] [Related]
17. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Ferraris O, Kessler N, Lina B. Antiviral Res; 2005 Oct 29; 68(1):43-8. PubMed ID: 16125799 [Abstract] [Full Text] [Related]